{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:19:53Z","timestamp":1793841593127,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007427","name":"Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["30994-7"],"award-info":[{"award-number":["30994-7"]}],"id":[{"id":"10.13039\/501100007427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-022-01876-6","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T04:02:21Z","timestamp":1659585741000},"page":"2353-2364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Natural history of subclinical hypothyroidism and prognostic factors for the development of overt hypothyroidism: Tehran Thyroid Study (TTS)"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1046-0003","authenticated-orcid":false,"given":"A.","family":"Amouzegar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"issue":"4","key":"1876_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/cpt.423","volume":"100","author":"NP Jewell","year":"2016","unstructured":"Jewell NP (2016) Natural history of diseases: statistical designs and issues. Clin Pharmacol Ther 100(4):353\u2013361","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"1876_CR2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archinte.160.4.526","volume":"160","author":"GJ Canaris","year":"2000","unstructured":"Canaris GJ, Manowitz NR, Mayor G, Ridgway EC (2000) The Colorado thyroid disease prevalence study. Arch Intern Med 160(4):526\u2013534","journal-title":"Arch Intern Med"},{"issue":"5","key":"1876_CR3","first-page":"516","volume":"35","author":"H Delshad","year":"2012","unstructured":"Delshad H, Mehran L, Tohidi M, Assadi M, Azizi F (2012) The incidence of thyroid function abnormalities and natural course of subclinical thyroid disorders, Tehran, I.R., Iran. J Endocrinol Invest 35(5):516\u201321","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1876_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1365-2265.1988.tb03651.x","volume":"28","author":"BU Althaus","year":"1988","unstructured":"Althaus BU, Staub JJ, Ryff-De Leche A, Oberhansli A, Stahelin HB (1988) LDL\/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol (Oxf) 28(2):157\u2013163","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1876_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","volume":"132","author":"AE Hak","year":"2000","unstructured":"Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med 132(4):270\u2013278","journal-title":"Ann Intern Med"},{"issue":"7\u20138","key":"1876_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/0024-3205(82)90281-8","volume":"30","author":"EC Ridgway","year":"1982","unstructured":"Ridgway EC, Ladenson PW, Cooper DS, Daniels GH, Francis GS, Maloof F (1982) Cardiac function in mild and severe primary hypothyroidism. Life Sci 30(7\u20138):651\u2013658","journal-title":"Life Sci"},{"issue":"3","key":"1876_CR7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1176\/ajp.150.3.508","volume":"150","author":"JJ Haggerty Jr","year":"1993","unstructured":"Haggerty JJ Jr, Stern RA, Mason GA, Beckwith J, Morey CE, Prange AJ Jr (1993) Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psychiatry 150(3):508\u2013510","journal-title":"Am J Psychiatry"},{"issue":"14","key":"1876_CR8","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1001\/archinte.1995.00430140052004","volume":"155","author":"T Diekman","year":"1995","unstructured":"Diekman T, Lansberg PJ, Kastelein JJ, Wiersinga WM (1995) Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med 155(14):1490\u20131495","journal-title":"Arch Intern Med"},{"issue":"6","key":"1876_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0002-9343(92)90782-7","volume":"92","author":"JJ Staub","year":"1992","unstructured":"Staub JJ, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K et al (1992) Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 92(6):631\u2013642","journal-title":"Am J Med"},{"issue":"9821","key":"1876_CR10","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(11)60276-6","volume":"379","author":"DS Cooper","year":"2012","unstructured":"Cooper DS, Biondi B (2012) Subclinical thyroid disease. Lancet 379(9821):1142\u20131154","journal-title":"Lancet"},{"issue":"10","key":"1876_CR11","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.1210\/jc.2003-032061","volume":"89","author":"JJ Diez","year":"2004","unstructured":"Diez JJ, Iglesias P (2004) Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab 89(10):4890\u20134897","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1876_CR12","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1210\/jcem.87.7.8678","volume":"87","author":"G Huber","year":"2002","unstructured":"Huber G, Staub JJ, Meier C, Mitrache C, Guglielmetti M, Huber P et al (2002) Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 87(7):3221\u20133226","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1876_CR13","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1089\/thy.2010.0411","volume":"21","author":"M Imaizumi","year":"2011","unstructured":"Imaizumi M, Sera N, Ueki I, Horie I, Ando T, Usa T et al (2011) Risk for progression to overt hypothyroidism in an elderly Japanese population with subclinical hypothyroidism. Thyroid 21(11):1177\u20131182","journal-title":"Thyroid"},{"issue":"1","key":"1876_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2265.1991.tb01739.x","volume":"34","author":"JV Parle","year":"1991","unstructured":"Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC (1991) Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 34(1):77\u201383","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1876_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/thy.2008.0221","volume":"19","author":"PW Rosario","year":"2009","unstructured":"Rosario PW, Bessa B, Valadao MM, Purisch S (2009) Natural history of mild subclinical hypothyroidism: prognostic value of ultrasound. Thyroid 19(1):9\u201312","journal-title":"Thyroid"},{"issue":"6","key":"1876_CR16","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/cen.12939","volume":"84","author":"PW Rosario","year":"2016","unstructured":"Rosario PW, Carvalho M, Calsolari MR (2016) Natural history of subclinical hypothyroidism with TSH <\/=10 mIU\/l: a prospective study. Clin Endocrinol (Oxf) 84(6):878\u2013881","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1876_CR17","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1210\/jc.2011-3047","volume":"97","author":"LL Somwaru","year":"2012","unstructured":"Somwaru LL, Rariy CM, Arnold AM, Cappola AR (2012) The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab 97(6):1962\u20131969","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1876_CR18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1530\/EJE-10-1021","volume":"164","author":"J Karmisholt","year":"2011","unstructured":"Karmisholt J, Andersen S, Laurberg P (2011) Variation in thyroid function in subclinical hypothyroidism: importance of clinical follow-up and therapy. Eur J Endocrinol 164(3):317","journal-title":"Eur J Endocrinol"},{"issue":"13","key":"1876_CR19","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.2018.13770","volume":"320","author":"M Feller","year":"2018","unstructured":"Feller M, Snel M, Moutzouri E, Bauer DC, de Montmollin M, Aujesky D et al (2018) Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism: a systematic review and meta-analysis. JAMA 320(13):1349\u20131359","journal-title":"JAMA"},{"issue":"2","key":"1876_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1001\/jama.291.2.228","volume":"291","author":"MI Surks","year":"2004","unstructured":"Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH et al (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291(2):228\u2013238","journal-title":"JAMA"},{"issue":"1","key":"1876_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/thy.2010.0092","volume":"21","author":"L Boucai","year":"2011","unstructured":"Boucai L, Hollowell JG, Surks MI (2011) An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid 21(1):5\u201311","journal-title":"Thyroid"},{"issue":"12","key":"1876_CR22","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1210\/jc.2007-1499","volume":"92","author":"MI Surks","year":"2007","unstructured":"Surks MI, Hollowell JG (2007) Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 92(12):4575\u20134582","journal-title":"J Clin Endocrinol Metab"},{"key":"1876_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1745-6215-10-5","volume":"10","author":"F Azizi","year":"2009","unstructured":"Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M et al (2009) Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials 10:5","journal-title":"Trials"},{"issue":"7","key":"1876_CR24","first-page":"418","volume":"16","author":"F Azizi","year":"2013","unstructured":"Azizi F, Amouzegar A, Delshad H, Tohidi M, Mehran L, Mehrabi Y (2013) Natural course of thyroid disease profile in a population in nutrition transition: Tehran thyroid study. Arch Iran Med 16(7):418\u2013423","journal-title":"Arch Iran Med"},{"issue":"11","key":"1876_CR25","first-page":"950","volume":"36","author":"A Amouzegar","year":"2013","unstructured":"Amouzegar A, Delshad H, Mehran L, Tohidi M, Khafaji F, Azizi F (2013) Reference limit of thyrotropin (TSH) and free thyroxine (FT4) in thyroperoxidase positive and negative subjects: a population based study. J Endocrinol Invest 36(11):950\u2013954","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1876_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.beem.2011.12.004","volume":"26","author":"B Biondi","year":"2012","unstructured":"Biondi B (2012) Natural history, diagnosis and management of subclinical thyroid dysfunction. Best Pract Res Clin Endocrinol Metab 26(4):431\u2013446","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"1876_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000356507","volume":"2","author":"SH Pearce","year":"2013","unstructured":"Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S et al (2013) 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J 2(4):215\u2013228","journal-title":"Eur Thyroid J"},{"issue":"3","key":"1876_CR28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1089\/thy.2015.0276","volume":"26","author":"A Amouzegar","year":"2016","unstructured":"Amouzegar A, Bakhtiyari M, Mansournia MA, Etemadi A, Mehran L, Tohidi M et al (2016) Sex- and age-specific reference values and cutoff points for TPOAb: Tehran thyroid study. Thyroid 26(3):458\u2013465","journal-title":"Thyroid"},{"issue":"26","key":"1876_CR29","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1056\/NEJMoa054022","volume":"354","author":"W Teng","year":"2006","unstructured":"Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D et al (2006) Effect of iodine intake on thyroid diseases in China. N Engl J Med 354(26):2783\u20132793","journal-title":"N Engl J Med"},{"issue":"3","key":"1876_CR30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1210\/jcem.83.3.4624","volume":"83","author":"P Laurberg","year":"1998","unstructured":"Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR (1998) Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland. Denmark J Clin Endocrinol Metab 83(3):765\u2013769","journal-title":"Denmark J Clin Endocrinol Metab"},{"issue":"1","key":"1876_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3803\/EnM.2014.29.1.20","volume":"29","author":"YA Kim","year":"2014","unstructured":"Kim YA, Park YJ (2014) Prevalence and risk factors of subclinical thyroid disease. Endocrinol Metab 29(1):20\u201329","journal-title":"Endocrinol Metab"},{"issue":"4","key":"1876_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1507\/endocrj.EJ16-0549","volume":"64","author":"X Li","year":"2017","unstructured":"Li X, Zhen D, Zhao M, Liu L, Guan Q, Zhang H et al (2017) Natural history of mild subclinical hypothyroidism in a middle-aged and elderly Chinese population: a prospective study. Endocr J 64(4):437\u2013447","journal-title":"Endocr J"},{"issue":"11","key":"1876_CR33","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.3346\/jkms.2013.28.11.1622","volume":"28","author":"WR Park","year":"2013","unstructured":"Park WR, Oh TK, Jeon HJ (2013) Prospective observation of 5-year clinical course of subclinical hypothyroidism in Korean population. J Korean Med Sci 28(11):1622\u20131626","journal-title":"J Korean Med Sci"},{"issue":"8","key":"1876_CR34","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1001\/archinte.1993.00410080025004","volume":"153","author":"UM Kabadi","year":"1993","unstructured":"Kabadi UM (1993) \u201cSubclinical hypothyroidism\u201d. Natural course of the syndrome during a prolonged follow-up study. Arch Intern Med 153(8):957\u201361","journal-title":"Arch Intern Med"},{"issue":"5","key":"1876_CR35","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1210\/jc.2011-3020","volume":"97","author":"AP Bremner","year":"2012","unstructured":"Bremner AP, Feddema P, Leedman PJ, Brown SJ, Beilby JP, Lim EM et al (2012) Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab 97(5):1554\u20131562","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1876_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/jama.1987.03400020051029","volume":"258","author":"MJ Rosenthal","year":"1987","unstructured":"Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS (1987) Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy. JAMA 258(2):209\u201313","journal-title":"JAMA"},{"issue":"1","key":"1876_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","volume":"43","author":"MP Vanderpump","year":"1995","unstructured":"Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 43(1):55\u201368","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"1876_CR38","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1210\/jc.2009-1977","volume":"95","author":"JP Walsh","year":"2010","unstructured":"Walsh JP, Bremner AP, Feddema P, Leedman PJ, Brown SJ, O\u2019Leary P (2010) Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab 95(3):1095\u20131104","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1876_CR39","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3803\/EnM.2021.1066","volume":"36","author":"WS Yoo","year":"2021","unstructured":"Yoo WS, Chung HK (2021) Subclinical hypothyroidism: prevalence, health impact, and treatment landscape. Endocrinol Metab 36(3):500\u2013513","journal-title":"Endocrinol Metab"},{"issue":"3","key":"1876_CR40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2265.1993.tb01006.x","volume":"38","author":"N Konno","year":"1993","unstructured":"Konno N, Yuri K, Taguchi H, Miura K, Taguchi S, Hagiwara K et al (1993) Screening for thyroid diseases in an iodine sufficient area with sensitive thyrotropin assays, and serum thyroid autoantibody and urinary iodide determinations. Clin Endocrinol (Oxf) 38(3):273\u2013281","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1876_CR41","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1210\/jc.2008-0101","volume":"93","author":"J Karmisholt","year":"2008","unstructured":"Karmisholt J, Andersen S, Laurberg P (2008) Interval between tests and thyroxine estimation method influence outcome of monitoring of subclinical hypothyroidism. J Clin Endocrinol Metab 93(5):1634\u20131640","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1876_CR42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jama.2019.9052","volume":"322","author":"B Biondi","year":"2019","unstructured":"Biondi B, Cappola AR, Cooper DS (2019) Subclinical hypothyroidism: a review. JAMA 322(2):153\u2013160","journal-title":"JAMA"},{"key":"1876_CR43","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/IJGM.S252114","volume":"13","author":"NA Saadeh","year":"2020","unstructured":"Saadeh NA, Saadeh R, Rousan LA, Rawashdeh D, Obeidat A, Saadeh AM (2020) Biochemical and ultrasound characteristics of subclinical hypothyroid patients in North of Jordan: who was treated? Int J Gen Med 13:305\u2013310","journal-title":"Int J Gen Med"},{"issue":"3","key":"1876_CR44","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1210\/jcem.87.3.8165","volume":"87","author":"S Andersen","year":"2002","unstructured":"Andersen S, Pedersen KM, Bruun NH, Laurberg P (2002) Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87(3):1068\u20131072","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01876-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01876-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01876-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T23:26:23Z","timestamp":1668209183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01876-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1876"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01876-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]},"assertion":[{"value":"26 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have any financial conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethics committee of the Research Institute for Endocrine Sciences (RIES), Shahid Beheshti University of Medical Sciences and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All procedures followed were in accordance with the ethical standards of the ethical standards of the ethics committee of the Research Institute for Endocrine Sciences (RIES), Shahid Beheshti University of Medical Sciences (IR.SBMU.ENDOCRINE.REC.1400.125) and with the Helsinki Declaration of 1964 and later versions.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}